Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteomyelitis | 9 | 2025 | 20 | 1.310 |
Why?
|
| Staphylococcal Infections | 4 | 2024 | 67 | 0.670 |
Why?
|
| Musculoskeletal Diseases | 3 | 2025 | 19 | 0.550 |
Why?
|
| Arthritis, Infectious | 2 | 2025 | 8 | 0.460 |
Why?
|
| Severity of Illness Index | 4 | 2024 | 719 | 0.410 |
Why?
|
| Child, Preschool | 12 | 2025 | 1546 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 587 | 0.300 |
Why?
|
| Synovial Fluid | 2 | 2025 | 6 | 0.280 |
Why?
|
| Child | 12 | 2025 | 3443 | 0.280 |
Why?
|
| Kidney Diseases | 3 | 2006 | 172 | 0.270 |
Why?
|
| Vitamin D Deficiency | 2 | 2005 | 107 | 0.250 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 3 | 2018 | 67 | 0.240 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2025 | 27 | 0.230 |
Why?
|
| Hyponatremia | 1 | 2005 | 6 | 0.230 |
Why?
|
| Hypernatremia | 1 | 2005 | 10 | 0.230 |
Why?
|
| Infant | 7 | 2025 | 1175 | 0.220 |
Why?
|
| Metagenomics | 1 | 2025 | 46 | 0.220 |
Why?
|
| Sodium | 1 | 2005 | 102 | 0.220 |
Why?
|
| Hospitals, Pediatric | 2 | 2025 | 22 | 0.210 |
Why?
|
| Workflow | 2 | 2025 | 26 | 0.210 |
Why?
|
| Acidosis | 1 | 2004 | 51 | 0.210 |
Why?
|
| Dietary Supplements | 1 | 2005 | 213 | 0.200 |
Why?
|
| Acute Disease | 5 | 2024 | 155 | 0.190 |
Why?
|
| Retrospective Studies | 7 | 2025 | 2544 | 0.190 |
Why?
|
| Proteomics | 1 | 2025 | 378 | 0.180 |
Why?
|
| Aging | 2 | 2005 | 783 | 0.180 |
Why?
|
| Bacteremia | 1 | 2022 | 37 | 0.180 |
Why?
|
| Bacteria | 1 | 2025 | 293 | 0.180 |
Why?
|
| Adolescent | 10 | 2025 | 6081 | 0.170 |
Why?
|
| Orthopedics | 1 | 2020 | 8 | 0.160 |
Why?
|
| Male | 18 | 2025 | 23409 | 0.160 |
Why?
|
| Humans | 26 | 2025 | 43102 | 0.160 |
Why?
|
| Female | 18 | 2025 | 24698 | 0.160 |
Why?
|
| Referral and Consultation | 1 | 2020 | 142 | 0.150 |
Why?
|
| Venous Thrombosis | 1 | 2018 | 30 | 0.140 |
Why?
|
| Weather | 1 | 2018 | 13 | 0.140 |
Why?
|
| Staphylococcus aureus | 3 | 2024 | 94 | 0.140 |
Why?
|
| Seasons | 1 | 2018 | 139 | 0.130 |
Why?
|
| Casts, Surgical | 1 | 2016 | 3 | 0.120 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2016 | 4 | 0.120 |
Why?
|
| Femoral Fractures | 1 | 2016 | 6 | 0.120 |
Why?
|
| Prospective Studies | 5 | 2025 | 1600 | 0.120 |
Why?
|
| Health Surveys | 3 | 2007 | 405 | 0.120 |
Why?
|
| Nutrition Surveys | 3 | 2008 | 263 | 0.120 |
Why?
|
| Texas | 3 | 2025 | 457 | 0.110 |
Why?
|
| Gene Expression Regulation | 2 | 2023 | 1070 | 0.110 |
Why?
|
| Glomerular Filtration Rate | 2 | 2005 | 147 | 0.110 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2025 | 203 | 0.110 |
Why?
|
| United States | 8 | 2020 | 5205 | 0.110 |
Why?
|
| Hypertension | 4 | 2007 | 835 | 0.100 |
Why?
|
| Aged | 7 | 2008 | 8214 | 0.090 |
Why?
|
| Cardiovascular Diseases | 3 | 2008 | 749 | 0.090 |
Why?
|
| Prognosis | 2 | 2024 | 861 | 0.090 |
Why?
|
| Risk Factors | 5 | 2019 | 3994 | 0.080 |
Why?
|
| Hypertension, Renal | 1 | 2008 | 16 | 0.070 |
Why?
|
| Chronic Disease | 3 | 2006 | 549 | 0.070 |
Why?
|
| Middle Aged | 7 | 2008 | 12222 | 0.060 |
Why?
|
| Prevalence | 4 | 2018 | 1612 | 0.060 |
Why?
|
| Albuminuria | 1 | 2006 | 78 | 0.060 |
Why?
|
| Age Factors | 2 | 2007 | 1154 | 0.060 |
Why?
|
| Benzothiadiazines | 1 | 2005 | 3 | 0.060 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 2005 | 7 | 0.060 |
Why?
|
| Vasopressins | 1 | 2005 | 12 | 0.060 |
Why?
|
| Vitamin D | 1 | 2007 | 196 | 0.060 |
Why?
|
| Education | 1 | 2005 | 60 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 2 | 2005 | 242 | 0.060 |
Why?
|
| Water-Electrolyte Balance | 1 | 2005 | 18 | 0.060 |
Why?
|
| Education, Medical, Continuing | 1 | 2005 | 35 | 0.060 |
Why?
|
| Diuretics | 1 | 2005 | 51 | 0.060 |
Why?
|
| Acid-Base Equilibrium | 1 | 2004 | 8 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 1067 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2006 | 1234 | 0.050 |
Why?
|
| ROC Curve | 1 | 2024 | 159 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 55 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2025 | 611 | 0.050 |
Why?
|
| Mexican Americans | 1 | 2005 | 226 | 0.050 |
Why?
|
| Homeostasis | 1 | 2004 | 192 | 0.050 |
Why?
|
| Kidney | 1 | 2005 | 372 | 0.050 |
Why?
|
| Poverty | 1 | 2006 | 400 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2004 | 233 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 235 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2005 | 193 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2019 | 36 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 704 | 0.040 |
Why?
|
| Adult | 5 | 2008 | 13872 | 0.040 |
Why?
|
| Contrast Media | 1 | 2019 | 103 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2002 | 666 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 432 | 0.040 |
Why?
|
| Pulmonary Embolism | 1 | 2018 | 38 | 0.030 |
Why?
|
| Obesity | 2 | 2007 | 1151 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2002 | 925 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2019 | 490 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 437 | 0.030 |
Why?
|
| Bone Nails | 1 | 2016 | 7 | 0.030 |
Why?
|
| Radiography | 1 | 2016 | 71 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 737 | 0.030 |
Why?
|
| Genetic Heterogeneity | 1 | 2015 | 11 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2018 | 1285 | 0.030 |
Why?
|
| Clinical Trials as Topic | 2 | 2008 | 259 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1078 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 1857 | 0.030 |
Why?
|
| Demography | 1 | 2015 | 195 | 0.030 |
Why?
|
| STAT4 Transcription Factor | 1 | 2014 | 3 | 0.030 |
Why?
|
| Resistin | 1 | 2014 | 4 | 0.030 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2014 | 14 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 246 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2014 | 34 | 0.030 |
Why?
|
| Neutrophils | 1 | 2014 | 145 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 167 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 515 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2014 | 171 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 1604 | 0.020 |
Why?
|
| Phylogeny | 1 | 2015 | 769 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 863 | 0.020 |
Why?
|
| Algorithms | 2 | 2004 | 509 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 5080 | 0.020 |
Why?
|
| Risk | 1 | 2008 | 287 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2006 | 2853 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2007 | 59 | 0.020 |
Why?
|
| Triglycerides | 1 | 2007 | 147 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 16992 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 211 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 638 | 0.010 |
Why?
|
| Data Collection | 1 | 2005 | 210 | 0.010 |
Why?
|
| Sex Factors | 1 | 2007 | 1028 | 0.010 |
Why?
|
| California | 1 | 2005 | 548 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 2004 | 78 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2004 | 223 | 0.010 |
Why?
|
| Indians, North American | 1 | 2005 | 192 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 2002 | 54 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 539 | 0.010 |
Why?
|
| Life Style | 1 | 2004 | 334 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2004 | 287 | 0.010 |
Why?
|
| Minority Groups | 1 | 2005 | 690 | 0.010 |
Why?
|
| Motivation | 1 | 2004 | 513 | 0.010 |
Why?
|